Open AccessLong-term outcome of chronic hepatitis C patients with sustained virological response to peginterferon plus ribavirin
Author(s) -
María Trapero-Marugán,
Jorge Mendoza,
María Chaparro,
Leticia González-Moreno,
J.A. Moreno-Monteagudo,
M.J. Borque,
Ricardo Moreno–Otero
Publication year - 2011
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v17.i4.493
Subject(s) - ribavirin , medicine , hepatocellular carcinoma , transient elastography , gastroenterology , cirrhosis , decompensation , pegylated interferon , hepatitis c , hepatitis c virus , immunology , virus , liver fibrosis
To assess the clinical, biochemical and virological long-term outcome in chronic hepatitis C (CHC) patients with a sustained virological response (SVR) after peginterferon (PEG-IFN) plus ribavirin combination therapy.